Introduction: The increase in the incidence and prevalence of dementia has changed the research focus towards its early identification. Several constructs have been developed in order to identify individuals with a high risk of developing dementia, with Mild Cognitive Impairment (MCI) being the term most commonly used in the last decades. However, diagnostic criteria for objective cognitive impairment have been modified using different methods and algorithms.

Aim: This paper aims to provide a review and update of diagnostic criteria for objective cognitive impairment to identify MCI.

Development: ProQuest, OVID SP, ScienceDirect and PSICODOC databases were used to find literature published since 1999 focused on diagnostic criteria for objective cognitive impairment applied to MCI. Papers written in Spanish or English were included.

Conclusions: From an initial search of 1954 articles, 17 were eventually reviewed. The original diagnostic criteria required low scores in one neuropsychological task, biasing MCI towards the amnesic type. Subsequent criteria expanded the number of tests in the battery, which allowed classifying MCI into amnesic and non-amnesic type, as well as into 'single-' and 'multiple' subtypes. Since increasing number of tests affected the probability of diagnostic errors, subsequent criteria incorporated normal variability for the identification of objective cognitive impairment. This work offers a critical review of the strengths and weaknesses of different diagnostic criteria for objective cognitive impairment, for use in both clinical and research settings on MCI and dementia.

Download full-text PDF

Source
http://dx.doi.org/10.33588/rn.7208.2020626DOI Listing

Publication Analysis

Top Keywords

cognitive impairment
32
objective cognitive
24
criteria objective
20
diagnostic criteria
20
criteria
8
cognitive
8
impairment
8
mild cognitive
8
mci amnesic
8
subsequent criteria
8

Similar Publications

A healthy diet is a key determinant of successful aging. However, the psychological, social, and physiological changes associated with ageing often disrupt dietary behaviours. Hungary has one of the highest rates of chronic age-related diseases in the European Union, exacerbated by unhealthy dietary patterns and rapid population aging.

View Article and Find Full Text PDF

Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer's disease.

Geroscience

January 2025

Psychology, School of Social Sciences, Nanyang Technological University, 48 Nanyang Avenue S639818, Singapore, Singapore.

In Alzheimer's disease (AD), the accumulation of neuropathological markers such as amyloid-β plaques, neurofibrillary tangles, and cortical neurodegeneration occurs over many years before overt manifestation of cognitive impairment. There is thus a need for neuropsychological markers that are indicative of pathological changes in the early stages of the disease. Intra-individual cognitive variability (IICV), defined as the variation of an individual's performance across cognitive domains, is a promising neuropsychological marker measuring heterogeneous changes in cognition that may reflect these early pathological changes.

View Article and Find Full Text PDF

Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer's disease patients.

Ann Nucl Med

January 2025

Department of Radiological Sciences, School of Health Science, Fukushima Medical University, 10-6 Sakae, Fukushima City, Fukushima, 960-8516, Japan.

Objective: This study aims to accurately classify ATN profiles using highly specific amyloid and tau PET ligands and MRI in patients with cognitive impairment and suspected Alzheimer's disease (AD). It also aims to explore the relationship between quantified amyloid and tau deposition and cognitive function.

Methods: Twenty-seven patients (15 women and 12 men; age range: 64-81 years) were included in this study.

View Article and Find Full Text PDF

Tirzepatide mitigates cognitive decline in zebrafish model of type 2 diabetes mellitus induced by high-fat diet.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Department of Pharmacology, ISF College of Pharmacy, Ghal Kalan, GT Road, Moga, 142001, Punjab, India.

In examining the enduring consequences of diabetes, recent research has focused on the anticipated outcomes of the condition. Specifically, cognitive impairment has been linked to diabetes mellitus dating back to the discovery of insulin. This study delves into the neuroprotective effects of TZP, i.

View Article and Find Full Text PDF

Stress is linked to oxidative imbalance, neuroendocrine system malfunction, and cognitive dysfunction. It is a recognized cause of neuropsychiatric diseases. Natural flavonoid apigenin (API) has neuroprotective and antidepressant properties, but little is known about its potential in restoring memory function under stress-related circumstances.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!